- UroToday Home
- Recent Abstracts
- Pelvic Health & Reconstruction
Overactive Bladder
Botulinum toxin versus sacral neuromodulation for idiopathic detrusor overactivity - Abstract
September 13, 2012
Neurogenic lower urinary tract dysfunction--do we need same session repeat urodynamic investigations? - Abstract
September 12, 2012
Analysis of the risk factors for overactive bladder on the basis of a survey in the community - Abstract
September 11, 2012
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder - Abstract
September 10, 2012
Association of symptoms with urodynamic findings in men with overactive bladder syndrome - Abstract
September 7, 2012
Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder - Abstract
September 6, 2012
International prostate symptom score for assessing lower urinary tract dysfunction in women - Abstract
September 4, 2012
Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders - Abstract
August 31, 2012
Effect of anticholinergic Use for the treatment of overactive bladder on cognitive function in postmenopausal women - Abstract
August 27, 2012
Dorsal genital nerve stimulation in patients with detrusor overactivity: A systematic review - Abstract
August 24, 2012
The role of neuromodulation in patients with neurogenic overactive bladder - Abstract
August 23, 2012
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females - Abstract
August 22, 2012
Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder - Abstract
August 21, 2012
